SSRI Discontinuation and Long-Term Remission Rates
Based on available evidence, approximately 40-46% of people remain off SSRIs for more than two years after discontinuation, meaning that 54-60% resume treatment within this timeframe.
Key Evidence on Long-Term Discontinuation
The most relevant data comes from a large UK national database study showing that among patients who had received SSRI prescriptions, approximately 40.8% had discontinued use after 1 year, 54.6% after 2 years, and 64.1% after 3 years 1. This means that conversely, about 45.4% remained off antidepressants beyond 2 years after stopping 1.
Additional supporting evidence from a study of Alzheimer's disease patients (which provides insight into general SSRI discontinuation patterns) found that 40.8% discontinued antidepressant use after 1 year and 54.6% after 2 years, with median duration of use being 309 days 2.
Factors Associated with Successful Discontinuation
Patients more likely to successfully discontinue SSRIs include:
- Younger patients (under age 85) 2
- Female patients (males more likely to discontinue) 2
- Those without multiple comorbidities such as diabetes 2
- Those not requiring concurrent psychotropic medications (benzodiazepines, antipsychotics, opioids) 2
Clinical Context: Relapse Risk After Discontinuation
The high rate of SSRI resumption reflects significant relapse risk. Studies examining medication discontinuation in PTSD patients found that 26-52% relapsed when shifted to placebo after successful SSRI treatment, compared to only 5-16% who continued medication 3. Another study showed 34% relapsed after fluoxetine discontinuation versus 17% who continued treatment 3.
Duration of Treatment and Discontinuation Success
Guideline recommendations suggest treatment duration significantly impacts long-term outcomes:
- First episode depression requires minimum 4-12 months of treatment before discontinuation should be considered 4
- Recurrent depression may require indefinite treatment, as relapse probability increases to 70% after two episodes and 90% after three episodes 4
- Over 60% of Americans on antidepressants have been taking them for more than 2 years, and 14% for 10 years or longer 4
Important Clinical Caveat
The data showing approximately 45% remaining off SSRIs beyond 2 years does not distinguish between:
- Patients who successfully recovered and no longer need treatment
- Patients who relapsed but chose not to resume medication
- Patients who switched to alternative treatments (psychotherapy, other medications)
This distinction is critical for patient counseling, as the relatively low long-term discontinuation success rate (45%) reflects both the chronic nature of depressive disorders and the high relapse risk when treatment is stopped prematurely 4, 1.